Christina Jenkins
Venture Partner @ Phoenix Venture Partners
Christina Jenkins is a Series A investor at Phoenix Venture Partners focused on Health Care and Medical Device. Dr. Christina Jenkins is a Venture Partner at Phoenix Venture Partners.
- Total investments:
- 23
- Last investment:
- Lead investor:
- 52%
Last updated:
For AI agents: llms.txt
Industries Christina Jenkins invests in
Stages Christina Jenkins invests in
Countries Christina Jenkins invests in
Round sizes
Round size
- Series A
- $1.5M–$25M
- Series B
- $31M–$31M
Investment Focus
Industry
- Health Care 8 (35%)
- Medical Device 4 (17%)
- mHealth 3 (13%)
- Women's 2 (9%)
- Wellness 2 (9%)
Stage
- Series A 4 (17%)
- Seed 2 (9%)
- Series B 2 (9%)
- Pre-Seed 1 (4%)
- Series C 1 (4%)
Country
- United States 7 (30%)
- Canada 1 (4%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
FIGUR8
|
FIGUR8 is an MIT spin-off company, creating the most advanced wearable musculoskeletal (MSK) technology on the market. The solution combines Smart Biosensors, Intuitive Software and AI to analyze and advance musculoskeletal health. Our solution accurately pinpoints the source of MSK pathology and provides essential data to enhance patient-centricrecovery. Value is recorded across the entire episode of care, from injury through full recovery. FIGUR8 technology aids in significantly reducing the cost of care, improving access, and empowering patients to take control of their personal MSK health. | $25M / Series A / Aug 08, 2023 | |
Xandar Kardian
|
Xandar Kardian provides commercially deployed 99.9% 'true' presence detection and people (occupancy) count solutions for smart building applications. It's patented and proprietary occupancy count system is the world's first and only commercial grade system that is able to count from any open space (virtual zones), making foottraffic counting possible in areas that was not possible with traditional cameras. Using micro-vibration patterns emitted from the body (chest movement from breathing, heart beat frequency from the heart (BPM) movement inside the body), XK is able to obtain 95% repetitive accurate RHR and RR measurements continuously. Occupant wellness - either in an office space, factory, hospital, nursing home or residential homes is now possible continuously, autonomously and without using any cameras or wearable devices. | $10M / Series A / Dec 14, 2021 | |
|
Xandar Kardian
|
Xandar Kardian provides commercially deployed 99.9% 'true' presence detection and people (occupancy) count solutions for smart building applications. It's patented and proprietary occupancy count system is the world's first and only commercial grade system that is able to count from any open space (virtual zones), making foottraffic counting possible in areas that was not possible with traditional cameras. Using micro-vibration patterns emitted from the body (chest movement from breathing, heart beat frequency from the heart (BPM) movement inside the body), XK is able to obtain 95% repetitive accurate RHR and RR measurements continuously. Occupant wellness - either in an office space, factory, hospital, nursing home or residential homes is now possible continuously, autonomously and without using any cameras or wearable devices. | $10M / Series A / Dec 14, 2021 | |
|
Xandar Kardian
|
Xandar Kardian provides commercially deployed 99.9% 'true' presence detection and people (occupancy) count solutions for smart building applications. It's patented and proprietary occupancy count system is the world's first and only commercial grade system that is able to count from any open space (virtual zones), making foottraffic counting possible in areas that was not possible with traditional cameras. Using micro-vibration patterns emitted from the body (chest movement from breathing, heart beat frequency from the heart (BPM) movement inside the body), XK is able to obtain 95% repetitive accurate RHR and RR measurements continuously. Occupant wellness - either in an office space, factory, hospital, nursing home or residential homes is now possible continuously, autonomously and without using any cameras or wearable devices. | Series A / Sep 03, 2021 | |
Madorra
|
Madorra Their goal is empowering women to live fuller, healthier lives. Madorra is working towards changing the paradigm for treating vaginal dryness, by providing a medical device solution to a problem that has previously only been served by pharmaceuticals. They are focused on giving post-menopausal women and breast cancer survivors the power tochoose the non-hormonal treatment option they want. | Seed / Dec 01, 2020 | |
|
Madorra
|
Madorra Their goal is empowering women to live fuller, healthier lives. Madorra is working towards changing the paradigm for treating vaginal dryness, by providing a medical device solution to a problem that has previously only been served by pharmaceuticals. They are focused on giving post-menopausal women and breast cancer survivors the power tochoose the non-hormonal treatment option they want. | Seed / Dec 01, 2020 | |
|
Madorra
|
Madorra Their goal is empowering women to live fuller, healthier lives. Madorra is working towards changing the paradigm for treating vaginal dryness, by providing a medical device solution to a problem that has previously only been served by pharmaceuticals. They are focused on giving post-menopausal women and breast cancer survivors the power tochoose the non-hormonal treatment option they want. | Series A / Dec 01, 2020 | |
|
Madorra
|
Madorra Their goal is empowering women to live fuller, healthier lives. Madorra is working towards changing the paradigm for treating vaginal dryness, by providing a medical device solution to a problem that has previously only been served by pharmaceuticals. They are focused on giving post-menopausal women and breast cancer survivors the power tochoose the non-hormonal treatment option they want. | Series A / Dec 01, 2020 | |
Siren Care
|
Siren Care is engaging with providers and payers to transform healthcare for chronic disease and aging. Siren significantly improves patient outcomes and experience by augmenting traditional healthcare with tech-enabled clinical models to provide whole person care. Our flagship program, the Siren Diabetic Foot Program, is a comprehensive servicepowered by our proprietary Siren Socks which monitor foot temperature continuously to deliver superior early detection of diabetic foot ulcers. | Series B / Aug 13, 2020 | |
|
Siren Care
|
Siren Care is engaging with providers and payers to transform healthcare for chronic disease and aging. Siren significantly improves patient outcomes and experience by augmenting traditional healthcare with tech-enabled clinical models to provide whole person care. Our flagship program, the Siren Diabetic Foot Program, is a comprehensive servicepowered by our proprietary Siren Socks which monitor foot temperature continuously to deliver superior early detection of diabetic foot ulcers. | Series B / Aug 13, 2020 | |
| See all 23 investments → | |||
Co-Investors
About Phoenix Venture Partners
Phoenix Venture Partners (PVP) is a venture capital firm that invests in and partners with entrepreneurs to commercialize breakthrough materials science innovations. PVP’s team has a track record of founding, building, and investing in successful materials science start-ups. The firm’s investment strategy is flexible and predicated on assistingentrepreneurs with customer and supply chain partnerships, business development, as well as strategic and operational support. PVP collaborates with a select set of forward-looking global corporations on business development and innovation interests.Phoenix Venture Partners was founded in 2010 and is based in Silicon Valley with satellite offices in Singapore and Cambridge, MA.
Phoenix Venture Partners Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Christina Jenkins
Venture Partner
|
|||
Jennifer Wang
CFO
|
|||
Nobuyuki Kambe
Managing General Partner
|
|||
Zach Jonasson
Managing General Partner
|
|||
David Soane
Special Partner
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does Christina Jenkins invest in?
Christina Jenkins invests primarily in Health Care, Medical Device and mHealth startups, most often at Series A and Seed stage. Most of the 23 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Christina Jenkins's check size?
Christina Jenkins typically joins rounds of $1.5M–$25M at Series A and $31M–$31M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Christina Jenkins participates in.
When did Christina Jenkins last invest?
The most recent investment recorded for Christina Jenkins closed in Aug 2023. Shizune tracks 23 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
